17β-estradiol modulation of angiotensin II-stimulated response in cardiac fibroblasts

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 1, 2006, Pages 97-107

  Stewart Jr , James A ^a   Cashatt, Dawn O ^a   Borck, Ashley C ^a   Brown, Jaime E ^a   Carver, Wayne E ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

17 estradiol; Angiotensin II; Collagen gel contraction; Estrogen; Fibroblasts; Heart; Integrins; MAP kinase; MMPs

Indexed keywords

ALPHA1 INTEGRIN; ANGIOTENSIN II; BETA1 INTEGRIN; COLLAGEN; ESTRADIOL; GELATINASE A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ESTROGEN ACTIVITY; FIBROBLAST; GENE EXPRESSION; MODULATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GEL; GENETICS; HEART; HEART MUSCLE; METABOLISM; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; COLLAGEN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FIBROBLASTS; GELS; HEART; INTEGRINS; MATRIX METALLOPROTEINASE 2; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; SIGNAL TRANSDUCTION;

EID: 33745353771     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.04.019     Document Type: Article

References (83)

1. Heart disease and stroke statistics-2003 update (2002), American Heart Association, Dallas, TX
2. Pelzer T, Shamim A, Neyses L. Estrogen effects in the heart. Mol Cell Biochem 1996 Jul;160-161:307-313.
3. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary disease in postmenopausal women. JAMA 280 (1998) 605-613
4. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
5. Bakir S., Mori T., Durand J., Chen Y.F., Thompson J.A., and Oparil S. Estrogen-induced vasoprotection is estrogen receptor dependent: evidence from the balloon-injured rat carotid artery model. Circulation 101 (2000) 2342-2344
6. Hayashi T., Jayachandran M., Sumi D., Thakur N.K., Esaki T., Muto E., et al. Physiological concentration of 17 beta-estradiol retards the progression of severe atherosclerosis induced by a high cholesterol diet plus balloon catheter injury: role of NO. Arterioscler Thromb Vasc Biol 20 (2000) 1613-1621
7. Anderson M.R., and Stender S. Endothelial nitric oxide synthase activity in aorta of normocholesterolemic rabbits: regional variation and the effect of estrogen. Cardiovasc Res 47 (2000) 192-199
8. Binko J., and Majewski H. 17 beta-estradiol reduces vasoconstriction in endothelial nitric oxide release to shear stress in arterioles of male hypertensive rats. Am J Physiol 274 (1998) H853-H859
9. Huang A., Sun D., Koller A., and Kaley G. 17beta-estradiol restores endothelial nitric oxide release to shear stress in arterioles of mal hypertensive rats. Circulation 101 (2000) 94-100
10. Nuedling S., Kahlert S., Loebbert K., Doevendans P.A., Meyer R., Vetter H., et al. 17β-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. Cardiovasc Res 43 (1999) 666-674
11. Morimoto K., Kurahashi Y., Shintani-Ishida K., Kawamura N., Miyashita M., Uji M., et al. Estrogen replacement suppresses stress-induced cardiovascular responses in ovariectomized rats. Am J Physiol, Heart Circ Physiol 287 (2004) H1950-H1956
12. Kuroski de Bold M.L. Estrogen, natriuretic peptides and the renin-angiotensin system. Cardiovasc Res 41 3 (1999 Mar) 524-531
13. Gallagher P.E., Li P., Lenhart J.R., Chappell M.C., and Brosnihan K.B. Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 33 (1999) 323-328
14. Regitz-Zagrosek V., Lehmkuhl E., Lemhkuhl H.B., and Hetzer R. Gender aspects in heart failure. Pathophysiology and medical therapy. Arch Mal Coeur Vaiss 97 (2004) 899-908
15. Griendling K.K., Murphy T.J., and Alexander R.A. Molecular biology of the renin-angiotensin system. Circulation 87 (1993) 1816-1828
16. Juenemaitre X., Soubrier F., and Kotelevtsev Y.V. Molecular basis of human hypertension: role of angiotensinogen. Cell 71 (1992) 169-180
17. Linz W., Schölkens B.A., Lindpaintner K., and Ganten D. Cardiac renin-angiotensin system. Am J Hypertens 2 (1989) 307-310
18. Nickenig G., Baumer A., Grohé C., Kahlert S., Strehlow K., Rosenkranz S., et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97 (1998) 2197-2201
19. Brilla C.G., Reams G.P., Maisch B., and Weber K.T. Renin-angiotensin system and myocardial fibrosis in hypertension: regulation of the myocardial matrix. Eur Heart J 14 (1993) 57-61
20. Sun Y., Ramires F.J., Zhou G., Ganjam V.K., and Weber K.T. Fibrous tissue and angiotensin II. J Mol Cell Cardiol 29 8 (1997 Aug) 2001-2012
21. Schnee J.M., and Hsueh W.A. Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc Res 46 2 (2000 May) 264-268
22. Kawano H., Do Y.S., Kawano Y., Barr M., Law R.E., and Hsueh W.A. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 101 (2000) 1130-1137
23. MacKenna D., Summerour S.R., and Villarreal F.J. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc Res 46 2 (2000 May) 257-263
24. Borg T.K., Rubin K., Lundgren E., Borg K., and Obrink B. Recognition of extracellular matrix components by neonatal and adult cardiac myocytes. Dev Biol 104 1 (1984 Jul) 86-96
25. Carver W., Nagpal M.L., Nachtigal M., Borg T.K., and Terracio L. Collagen expression in mechanically stimulated cardiac fibroblasts. Circ Res 69 1 (1991 Jul) 116-122
26. Grohé C., Kahlert S., Löbbert K., Meyer R., Linz K.W., Karas R.H., et al. Modulation of hypertensive heart disease by estrogen. Steroids 61 (1996) 201-204
27. Grohé C., Kahlert S., Lobbert K., Neyses L., van Eickels M., Stimpel M., et al. Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. J Hypertens 16 (1998) 377-384
28. Nuedling S., Karas R.H., Mendelsohn M.E., Katzenellenbogen J.A., Katzenellebogen B.S., Meyer R., et al. Activation of estrogen receptor β is a prerequisite for estrogen- dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes. FEBS Lett 502 (2005) 103-108
29. 3 and fibronectin mRNAs but exhibits disparate action on cardiac fibroblast proliferation. Cardiovasc Res 53 (2002) 728-739
30. Carver W., Molano I., Reaves T.A., Borg T.K., and Terracio L. Role of the alpha 1 beta 1 integrin complex in collagen gel contraction in vitro by fibroblasts. J Cell Physiol 165 2 (1995 Nov) 425-437
31. Bell E., Ivarsson B., and Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci U S A 76 (1979) 1274-1278
32. Cid M.C., Esparza J., Schnaper H.W., Juan M., Yague J., Grant D.S., et al. Estradiol enhances endothelial cell interactions with extracellular matrix proteins via an increase in integrin expression and function. Angiogenesis 3 (1999) 271-280
33. Dubey R.K., Gillespie D.G., Jackson E.K., and Keller P.J. 17β-Estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension 31 (1998) 522-528
34. Hong H.J., Lui J.C., Chan P., Juan S.H., Loh S.H., Lin J.G., et al. 17β-Estradiol downregulates angiotensin II induced endothelin1 gene expression in rat aortic smooth muscle cells. J Biomed Sci 11 (2004) 27-36
35. Burgess M.L., Carver W.E., Terracio L., Wilson S.P., Wilson M.A., and Borg T.K. Integrin-mediated collagen gel contraction by cardiac fibroblasts. Effects of angiotensin II. Circ Res 74 2 (1994 Feb) 291-298
36. Terracio L., Rubin K., Gullberg D., Balog E., Carver W., Jyring R., et al. Expression of collagen binding integrins during cardiac development and hypertrophy. Circ Res 68 3 (1991 Mar) 734-744
37. Stewart Jr. J.A., Wei C.C., Brower G.L., Rynders P.E., Hankes G.H., Dillon A.R., et al. Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog. J Mol Cell Cardiol 35 (2003) 311-319
38. Watson S., Burnside T., and Carver W. Angiotensin II-stimulated collagen gel contraction by heart fibroblasts: role of the AT1 receptor and tyrosine kinase activity. J Cell Physiol 177 (1998) 224-231
39. Gullberg D., Tingstrom A., Thuresson A.C., Olsson L., Terracio L., Borg T.K., et al. Beta 1 integrin-mediated collagen gel contraction is stimulated by PDGF. Exp Cell Res 186 2 (1990 Feb) 264-272
40. Horackova M., and Armour J.A. ANG II modifies cardiomyocyte function via extracardiac and intracardiac neurons: in situ and in vitro studies. Am J Physiol 272 3 Pt 2 (1997 Mar) R766-R775
41. Chancey A.L., Brower G.L., and Janicki J.S. Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function. Am J Physiol, Heart Circ Physiol 282 6 (2002 Jun) H2152-H2158
42. Coker M.L., Thomas C.V., Clair M.J., Hendrick J.W., Krombach R.S., Galis Z.S., et al. Myocardial matrix metalloproteinase activity and abundance with congestive heart failure. Am J Physiol 274 5 Pt 2 (1998 May) H1516-H1523
43. Janicki J.S., Henegar J.R., Campbell S.E., and Tyagi S.C. Myocardial collagenase activity in experimental dilated cardiomyopathy. In: Weber K.T. (Ed). Wound healing responses in cardiovascular diseases (1995), Futura Press, New York 73-81
44. Peterson J.T., Hallak H., Johnson L., Li H., O'Brien P.M., Sliskovic D.R., et al. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 103 18 (2001 May 8) 2303-2309
45. Spinale F.G., Coker M.L., Thomas C.V., Walker J.D., Mukherjee R., and Hebbar L. Time- dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res 82 4 (1998 Mar 9) 482-495
46. Borg K.T., Burgess W., Terracio L., and Borg T.K. Expression of metalloproteases by cardiac myocytes and fibroblasts in vitro. Cardiovasc Pathol 6 (1997) 261-269
47. Chao H.H., Chen J.J., Chen C.H., Lin H., Cheng W.S., Lian W.S., et al. Inhibition of angiotensin II induced endothelin-1 gene expression by 17β-oestradiol in rat cardiac fibroblasts. Heart 91 (2006) 664-669
48. Kawano H., Cody R.J., Graf K., Goetze S., Kawano Y., Schnee J., et al. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts. Hypertension 35 1 Pt 2 (2000 Jan) 273-279
49. Nunohiro T., Ashizawa N., Graf K., Hsueh W.A., and Yano K. Angiotensin II promotes integrin-mediated collagen gel contraction by adult rat cardiac fibroblasts. Jpn Heart J 40 4 (1999 Jul) 461-469
50. Woodward T.L., Mienaltowski A.S., Modi R.R., Bennett J.M., and Haslam S.Z. Fibronectin and the α5β1 integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland. Endocrinology 142 (2001) 3214-3222
51. Iype T., Jayasree K., and Sudhakaran P.R. Modulation of α2β1 integrin changes during mammary gland development by β-oestradiol. Biochim Biophys Acta 1499 (2001) 232-241
52. Haslam S.Z., and Woodward T.L. Tumour-stroma interactions: reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland. Breast Cancer Res 3 (2001) 365-372
53. Chancey A.L., Gardner J.D., Murray D.B., Brower G.L., and Janicki J.S. Modulation of cardiac mast cell mediated extracellular matrix degradation by estrogen. Am J Physiol, Heart Circ Physiol 289 (2005) H316-H321
54. Goffin F., Munaut C., Frankenne F., d'Hauterive S.P., Béliard A., Fridman V., et al. Expression pattern of metlloproteinases and tissue inhibitors of matrix- metalloproteinases in cycling human endometrium. Biol Reprod 69 (2003) 976-984
55. Xu Y., Arenas I.A., Armstrong S.J., and Davidage S.T. Estrogen modulation of left ventricular remodeling in the aged heart. Cardiovasc Res 57 (2003) 388-394
56. Zecchin K.G., Pereira M.C., Coletta R.D., Graner E., and Jorge J. Ovariectomy reduces the gelatinolytic activity and expression of matrix metalloproteinases and collagen in rat molar extraction wounds. Calcif Tissue Int 76 (2005) 136-145
57. Chu P.Y., Salamonsen L.A., Lee C.S., and Wright P.J. Matris metalloproteinases (MMPs) in the endometrium of bitches. Reproduction 123 (2002) 467-477
58. Wingrove C.S., Garr E., Godsland I.F., and Stevenson J.C. 17β-Oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1406 (1998) 169-174
59. Shi Y., Patel S., Niculescu R., Chung W., Desrochers P., and Zalewski A. Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. Arterioscler Thromb Vasc Biol 19 (1999) 1150-1155
60. Johnson C., and Galis Z.S. Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol 24 (2004) 54-60
61. de Almeida A., Mustin D., Forman M.F., Brower G.L., Janicki J.S., and Carver W. Effects of mast cells on the behavior of isolated heart fibroblasts: modulation of collagen remodeling and gene expression. J Cell Physiol 191 1 (2002 Apr) 51-59
62. Falkenstein E., Tilmann H.C., Christ M., Feuring M., and Wehling M. Multiple actions of steroid hormones: a focus on rapid nongenomic effects. Pharmacol Rev 52 (2000) 513-556
63. Luconi M., Francavilla F., Porazzi I., Macerola B., Forti G., and Baldi E. Human spermatozoa as a model for studying membrane receptors mediating rapid nongenomic effects of progesterone and estrogens. Steroids 69 (2004) 553-559
64. Morley P., Whitefield J.F., Vanderhyden B.C., Tsang B.K., and Schwartz J.L. A new nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 131 (1992) 1305-1312
65. Honda K., Sawada H., Kihara T., Urushitani M., Nakamizo T., Akaike A., et al. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured corticol neurons. Neurosci Res 60 (2000) 321-327
66. Russell K.S., Haynes M.P., Sinha D., Clerisme E., and Bender J.R. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci U S A 97 (2000) 5930-5935
67. Song R.X., McPherson A., Adam L., Bao Y., Shupnik M., Kumar R., et al. Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Mol Endocrinol 16 (2002) 116-127
68. Chen Z., Yuhanna S.Y., Galchava-Gargova Z., Karas R.H., Mendelsohn M.E., and Shaul P.W. Estrogen receptor β mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103 (1999) 401-406
69. Haynes P.M., Sinha D., Russell K.S., Collinge M., Fulton D., Morales-Ruiz M., et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via PI3-kinase Akt pathway in human endothelial cells. Circ Res 37 (2000) 677-682
70. Moro L., Reineri S., Piranda D., Pietrapiana D., Lova P., Bertoni A., et al. Nongenomic effects of 17β-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen β and Src kinase. Blood 105 (2005) 115-121
71. van Eickels M., Grohé C., Cleutjens J.P.M., Janssen B.J., Wellens H.J.J., and Doevendans P.A. 17-β estradiol attenuates the development of pressure overload hypertrophy. Circulation 104 (2001) 1419-1423
72. Ogita H., Node K., Liao Y., Ishikura F., Beppu S., Asanum H., et al. Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice. Hypertension 43 (2004) 237-242
73. Takeda-Matsubara Y., Nakagami H., Iwai M., Cui T.X., Shiuchi T., Akishita M., et al. Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II. Hypertension 39 (2002) 41-45
74. Morey A.K., Razandi M., Pedram A., Hu R.M., Prins B.A., and Levin E.R. Oestrogen and progesterone inhibit the stimulated production of endothelin-1. Biochem J 330 (1998) 1097-1105
75. Schorb W., Conrad K.M., Singer H.A., Dostal D.E., and Baker K.M. Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts. J Mol Cell Cardiol 27 (1995) 1151-1160
76. Gilad L.A., Bresler T., Gnainsky J., Smirnoff P., and Schwartz B. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. J Endocrinol 185 (2005) 577-592
77. Bulayeva N.N., Gametchu B., and Watson C.S. Quantitative measurement of estrogen- induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids 69 (2004) 181-192
78. Wong C.W., McNally C., Nickbarg E., Komm B.S., and Cheskis B.J. Estrogen receptor- interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci U S A 99 (2002) 14783-14788
79. Suarez C., Diaz-Torga G., Gonzalez-Iglesias A., Cristina C., and Becu-Villalobos D. Upregulation of angiotensin II type 2 receptor expression in estrogen-induced pituitary hyperplasia. Am J Physiol: Endocrinol Metab 286 (2004) E786-E794
80. Wu Z., Zheng W., and Sandberg K. Estrogen regulates adrenal angiotensin type 1 receptors by modulating adrenal angiotensin levels. Endocrinology 144 (2003) 1350-1356
81. Joren O., Sanvitto G.L., Egidy G., and Saavedra J.M. Angiotensin II AT1A receptor mRNA expression is reduced by estrogen-progesterone in dopaminergic neurons of the female rat arcuate nucleus. J Neurosci 17 (1997) 8283-8292
82. Baiardi G., Macova M., Armando I., Ando H., Tyurmin D., and Saavedra J.M. Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat. Regul Pept 124 (2005) 7-17
83. Nunohiro T., Ashizawa N., Graf K., Do Y.S., Hsueh W.A., and Yano K. Angiotensin II promotes remodelling-related events in cardiac fibroblasts. Heart Vessels 12 Suppl (1997) 201-204